Tokyo, Japan

Yashushi Okazaki


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yashushi Okazaki: Innovator in Pharmaceutical Chemistry

Introduction

Yashushi Okazaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on creating innovative solutions to address health challenges.

Latest Patents

One of Okazaki's notable patents is titled "Novel benzylalcohol derivatives and processes for preparing the same." This patent describes a compound that can be synthesized through various methods, including the reduction of specific precursors. The compound and its pharmaceutically acceptable acid addition salt are recognized for their potential as anti-diabetic agents. This innovation highlights Okazaki's commitment to advancing medical science through his research.

Career Highlights

Yashushi Okazaki is associated with Tanabe Seiyaku Company, Limited, where he continues to contribute to the development of pharmaceutical products. His expertise in chemical processes and compound synthesis has positioned him as a valuable asset in the industry. With a focus on practical applications, Okazaki's work aims to improve patient outcomes through effective medication.

Collaborations

Okazaki has collaborated with notable colleagues, including Muneyoshi Ikezaki and Nobuo Ito. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field of pharmaceutical research.

Conclusion

Yashushi Okazaki's contributions to pharmaceutical chemistry, particularly through his patent on novel benzylalcohol derivatives, underscore his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…